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The repeated deployment of troops does not increase exponentially the risk of being killed; it also involves an increasing exposure to 
iatrogenic factors [1]. Indeed, “deployment to a war zone is an experience that may profoundly impact a veteran’s health and personal life, 
carrying the risk of long-term physical, psychological, and social impairments” [2]. Obviously, this risk is significantly different between 
members serving in the red high-exposure areas (e.g. intense firefight or battle with a great deal of injury and killing) or in the green low-
exposure areas (e.g. killed-in-action comrades’ bodies preparation for return stateside) [1,3]. Each of these exposures is potentially devas-
tating and may actually cause similar symptoms, but clearly, they are different. The major signature conditions of the wars for US member 
service and veterans are traumatic brain injury resulting from current combat operations (mTBI/concussion) and PTSD [1]. Macera and 
colleagues [4] pointed out that blast-related injuries might disclose the development/worsening of symptoms during the months follow-
ing deployment. Importantly, those who have been affected by PTSD and TBI in Operation Iraqi Freedom formed a unique group, with the 
presence of TBI intensifying development of PTSD symptomatology [4]. 
In 2014, the United States Senate designated the month of June as post-traumatic stress disorder (PTSD) Awareness Month. The Na-
tional Center for PTSD (www.ptsd.va.gov) invites everyone to collaborate. The actions of this initiative are summarized in: LEARN about 
PTSD, CONNECT to resources that can help; SHARE with others to spread the word. 
2.77 million US military personnel have served in Afghanistan and Iraq in Operation Enduring Freedom (OEF), Operation Iraqi Free-
dom (OIF), and Operation New Dawn (OND) since the beginning of these conflicts in 2001. These major international conflicts were the 
first since the Vietnam War that required a great number of troops on the ground. About 50 nations have contributed troops to both con-
flict areas, but the majority of those deployed at any one time have been from the US: as of March, there were about 13,500 NATO troops in 
Afghanistan, including about 9,000 Americans. Considering the years before, between September 2001 and 2015, 1.33 million individuals 
serving with the Army deployed abroad, along with 563,000 from the Navy, 518,000 from the Air Force and 367,000 Marines. Quite a 
few service members have multiple deployments under their belts with around 225,000 soldiers from the Army deploying at least three 
times or more, particularly those in the special operations community. To mention one of these extreme situations, we want to remember 
the case of Delta Force Master Sgt. Joshua L. Wheeler who became the first US soldier to die in combat against ISIS and the first American 
to lose his life in Iraq for four years. After he died during a successful raid on an ISIS prison facility during Operation Inherent Resolve, it 
emerged that he was a veteran of 14 combat deployments to Iraq and Afghanistan.
596
Post-Deployment Syndrome in U.S. Active Duty Military and Veterans. The Difficulty in Recognizing the “Illness of War”
Citation: Sara Palermo. “Post-Deployment Syndrome in U.S. Active Duty Military and Veterans. The Difficulty in Recognizing the “Illness of War””. EC Psychology and Psychiatry 7.9 (2018): 595-596.
Clinical and research experts do not fully agree on what PDS is, when symptoms reach a threshold to be labeled as PDS or when they’re 
something else, and when the same symptoms are significant enough to warrant different types of treatments [3]. Despite this difficulty 
in recognizing the syndrome, many service members and veterans report common symptoms that appear to be “PDS drivers”, such as 
difficulty falling or staying asleep irritability, headaches, and poor concentration [3]. More than a dozen of chronic unexplained symptoms 
might complete the PDS constellation: anxiety, appetite abnormalities, changes in taste/smell, depression, difficulty hearing, difficulty 
in making decision, dizziness, fatigue/loss of energy, loss of balance; memory complaints, nausea, nightmares, numbness in parts of 
the body, poor coordination/clumsiness, poor frustration tolerance, poor concentration sensitivity to noise/lights, slowed thinking, vi-
sion problems/blurring [3,5]. Moreover, chronic widespread pain is a component of this syndrome, producing significant disability and 
considerable health care costs [5]. To use the words of Cifu and Blake [4], the presence of PDS is reasonably suspected when soldiers are 
dealing with “more than just a single symptom or two, more than just the results of a single injury, more than just a reaction to stress, and 
more than just some minor difficulty readjusting to home after a tour of duty” [3]. Importantly, this symptom constellation must “be fairly 
consistent in nature and intensity, be significant enough to limit some aspect of your day-to-day functioning, be there for at least 3 months 
after all physical injuries have healed, and/or be there for at least 3 months after a return to home”.
Considering the above, it is important that all health care personnel be familiar with the unique health care needs of active duty and 
veterans, which include not only injuries associated with blast exposures (including mTBI/concussion), but also several mental health conditions, such as combat stress disorders, PTSD and PDS. Other important health concerns must be considered chronic unexplained 
medical symptoms, as well as musculoskeletal pain and hypertension, sequelae of environmental exposures, behavioral abnormalities 
and depression, substance abuse, sleep disturbances, and impairments in family, occupational and social functioning [2]. All these condi-
tions can affect more or less seriously on soldiers’ health and day-to-day functioning. Importantly, these dysfunctions persist long after 
the initial insult or injury is over, and anyway over the period of adaptation to being back-home has been completed or the times typically needed to heal.
Although PDS has traditionally been attributed to combat exposure, it is also true that in any war troops that were in the rear have de-
veloped the same symptom constellation. Indeed, “providers should recognize the late development of symptoms, consider the possibility 
of comorbidity, and be prepared to treat multiple symptoms rather than a specific diagnostic category” [4].
However, the majority of health, neuropsychiatric and neuropsychological complaints for the military personnel are relatively under-
estimated. In particular, it is supposed that approximately one in five men and women returning from service in Iraq and Afghanistan 
experience lasting physical and psychological injuries consistent with Post-Deployment Syndrome (PDS). Some conservative estimates 
confirm that at least 400,000 U.S. troops have been impacted with PDS [3]. This syndrome incorporates all the signs and symptoms expe-
rienced because of the injury, deprivation, trauma, and stress of combat [3].
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